Share Data

At Anavex Life Sciences, we strive to produce sustained strong performance and shareholder value.

NASDAQ: AVXL

Industry

Biopharmaceutical

Sector

New drug discovery

Fiscal year end

September 30

Shares issued and outstanding

85,893,834*

Stock purchase warrants

10,000 **

Stock options

15,453,566**

Fully diluted

100,875,258**

Cash

$101.2 million

Debt

Nil **

Trading symbol

AVXL

52-week range

$5.03 - $14.44

Financial statements and filings

Anavex's filings can be found on EDGAR

Investor relations

Transfer agent

Nevada Agency and Trust

50 West Liberty Street,

Suite 880

Reno, Nevada 89501

Fax: (775) 322-5623

Resident Agent

NATIONAL REGISTERED AGENTS, INC.
701 S Carson ST STE 200, Carson City, NV, 89701, USA

* As of August 12, 2025

** As of June 30, 2025

Forms - Reverse Stock Split

Internal Revenue Service (United States) - Form 8937